Zimmer Biomet Holdings Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Zimmer Biomet Holdings ha aumentado sus beneficios a una tasa media anual de 35.5%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 13.5% anual. Los ingresos han ido disminuyendo a una tasa media de 2.3% al año. La rentabilidad financiera de Zimmer Biomet Holdings es de 8.2%, y sus márgenes netos son de 13.8%.
Información clave
35.5%
Tasa de crecimiento de los beneficios
35.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 8.9% |
| Tasa de crecimiento de los ingresos | -2.3% |
| Rentabilidad financiera | 8.2% |
| Margen neto | 13.8% |
| Próxima actualización de resultados | 02 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20
Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Apr 02Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Appealing
Mar 13A Look At The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Feb 21Improving Ortho Performance At Zimmer Biomet Is Encouraging
Feb 09Zimmer Biomet Q4 2022 Earnings Preview
Feb 02We Think Zimmer Biomet Holdings (NYSE:ZBH) Can Stay On Top Of Its Debt
Jan 19Zimmer Biomet to acquire soft tissue healing company Embody
Jan 05Zimmer Biomet declares $0.24 dividend
Dec 15Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Dec 03Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Could Be 26% Below Their Intrinsic Value Estimate
Nov 17Zimmer Biomet reports Q3 earnings beat; raises FY22 guidance range
Nov 02Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Oct 24Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Oct 10Zimmer's shoulder replacement system Identity gets FDA clearance
Sep 20Zimmer Biomet Is Likely Set For Even More Weakness (Technical Analysis)
Sep 14Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 12Zimmer, Surgical Planning team up to sell mixed reality navigation system HipInsight
Sep 01Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Aug 29Zimmer Biomet declares $0.24 dividend
Aug 26Zimmer Biomet: Slow Growing Market Leader
Aug 20Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 43%?
Aug 04Desglose de ingresos y gastosBeta
Desglose de ingresos y gastos
BetaCómo gana y gasta dinero Zimmer Biomet Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 7,394 | 1,024 | 2,793 | 459 |
| 30 Sep 23 | 7,279 | 474 | 2,768 | 453 |
| 30 Jun 23 | 7,196 | 506 | 2,757 | 438 |
| 31 Mar 23 | 7,108 | 450 | 2,727 | 420 |
| 31 Dec 22 | 6,940 | 290 | 2,668 | 406 |
| 30 Sep 22 | 6,892 | 366 | 2,649 | 394 |
| 30 Jun 22 | 6,908 | 334 | 2,632 | 386 |
| 31 Mar 22 | 6,889 | 325 | 2,631 | 452 |
| 31 Dec 21 | 6,827 | 445 | 2,626 | 436 |
| 30 Sep 21 | 7,135 | 834 | 2,787 | 440 |
| 30 Jun 21 | 7,379 | 914 | 2,915 | 432 |
| 31 Mar 21 | 6,842 | 563 | 2,886 | 355 |
| 31 Dec 20 | 6,128 | -11 | 2,524 | 323 |
| 30 Sep 20 | 7,065 | -152 | 3,030 | 393 |
| 30 Jun 20 | 7,028 | 37 | 3,042 | 422 |
| 31 Mar 20 | 7,791 | 377 | 3,221 | 446 |
| 31 Dec 19 | 7,982 | 1,132 | 3,279 | 449 |
| 30 Sep 19 | 7,928 | -90 | 3,331 | 429 |
| 30 Jun 19 | 7,872 | -359 | 3,299 | 411 |
| 31 Mar 19 | 7,891 | -308 | 3,268 | 398 |
| 31 Dec 18 | 7,933 | -379 | 3,372 | 392 |
| 30 Sep 18 | 7,930 | 1,753 | 3,119 | 386 |
| 30 Jun 18 | 7,907 | 1,690 | 3,071 | 381 |
| 31 Mar 18 | 7,849 | 1,689 | 3,029 | 375 |
| 31 Dec 17 | 7,803 | 1,814 | 3,096 | 370 |
| 30 Sep 17 | 7,748 | 652 | 2,988 | 371 |
| 30 Jun 17 | 7,768 | 712 | 3,012 | 375 |
| 31 Mar 17 | 7,752 | 497 | 2,972 | 371 |
| 31 Dec 16 | 7,668 | 306 | 2,906 | 366 |
| 30 Sep 16 | 7,604 | 363 | 2,900 | 356 |
| 30 Jun 16 | 7,534 | 227 | 2,865 | 344 |
| 31 Mar 16 | 6,767 | 84 | 2,577 | 306 |
| 31 Dec 15 | 5,998 | 147 | 2,284 | 269 |
| 30 Sep 15 | 5,287 | 174 | 2,000 | 229 |
| 30 Jun 15 | 4,631 | 325 | 1,730 | 192 |
| 31 Mar 15 | 4,646 | 670 | 1,730 | 188 |
| 31 Dec 14 | 4,673 | 720 | 1,751 | 187 |
| 30 Sep 14 | 4,691 | 802 | 1,789 | 188 |
| 30 Jun 14 | 4,659 | 784 | 1,804 | 191 |
| 31 Mar 14 | 4,646 | 764 | 1,818 | 198 |
| 31 Dec 13 | 4,623 | 780 | 1,749 | 203 |
| 30 Sep 13 | 4,563 | 678 | 1,817 | 213 |
| 30 Jun 13 | 4,514 | 702 | 1,809 | 217 |
Ingresos de calidad: ZBH tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (13.8%) de ZBH son superiores a los del año pasado (4.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ZBH ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 35.5% al año.
Acelerando crecimiento: El crecimiento de los beneficios de ZBH en el último año (252.9%) supera su media de 5 años (35.5% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de ZBH en el último año (252.9%) superó al de la industria Medical Equipment 3.3%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de ZBH (8.2%) se considera baja.